Cargando…

Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer

Patients with medullary thyroid cancer (MTC) are often diagnosed with spread tumour disease and the development of better systemic treatment options for these patients is important. Treatment with the radiolabelled somatostatin analogue (177)Lu-octreotate is already a promising option but can be opt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandblom, Viktor, Spetz, Johan, Shubbar, Emman, Montelius, Mikael, Ståhl, Ingun, Swanpalmer, John, Nilsson, Ola, Forssell-Aronsson, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855663/ https://www.ncbi.nlm.nih.gov/pubmed/31725814 http://dx.doi.org/10.1371/journal.pone.0225260

Ejemplares similares

Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors
por: Sandblom, Viktor, et al.
Publicado: (2020)

(177)Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition
por: Hofving, Tobias, et al.
Publicado: (2019)

Multiparametric MR for non‐invasive evaluation of tumour tissue histological characteristics after radionuclide therapy
por: Montelius, Mikael, et al.
Publicado: (2019)

Hyperfractionated Treatment with (177)Lu-Octreotate Increases Tumor Response in Human Small-Intestine Neuroendocrine GOT1 Tumor Model
por: Elvborn, Mikael, et al.
Publicado: (2022)

Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
por: Larsson, Malin, et al.
Publicado: (2020)

Correction: Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose 131I exposure
por: Larsson, Malin, et al.
Publicado: (2021)

Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to (177)Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor
por: Montelius, Mikael, et al.
Publicado: (2018)

Evaluation of two intraoperative gamma detectors for assessment of (177)Lu activity concentration in vivo
por: Sandblom, Viktor, et al.
Publicado: (2017)

Transcriptional effects of (177)Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice
por: Spetz, Johan, et al.
Publicado: (2019)

Non-targeted transcriptomic effects upon thyroid irradiation: similarity between in-field and out-of-field responses varies with tissue type
por: Langen, Britta, et al.
Publicado: (2016)

Neuroblastoma xenograft models demonstrate the therapeutic potential of (177)Lu-octreotate
por: Romiani, Arman, et al.
Publicado: (2021)

Age and sex effects across the blood proteome after ionizing radiation exposure can bias biomarker screening and risk assessment
por: Langen, Britta, et al.
Publicado: (2022)

Tumour size measurement in a mouse model using high resolution MRI
por: Montelius, Mikael, et al.
Publicado: (2012)

Priming increases the anti-tumor effect and therapeutic window of (177)Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1
por: Dalmo, Johanna, et al.
Publicado: (2017)

Deconvolution of expression microarray data reveals (131)I-induced responses otherwise undetected in thyroid tissue
por: Langen, Britta, et al.
Publicado: (2018)

Hedgehog inhibitor sonidegib potentiates (177)Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice
por: Spetz, Johan, et al.
Publicado: (2017)

Transcriptional response to (131)I exposure of rat thyroid gland
por: Rudqvist, Nils, et al.
Publicado: (2017)

Gene expression signature in mouse thyroid tissue after (131)I and (211)At exposure
por: Rudqvist, Nils, et al.
Publicado: (2015)

Co-administration with A1M does not influence apoptotic response of (177)Lu-octreotate in GOT1 neuroendocrine tumors
por: Rassol, Nishte, et al.
Publicado: (2023)

Data‐driven identification of tumor subregions based on intravoxel incoherent motion reveals association with proliferative activity
por: Jalnefjord, Oscar, et al.
Publicado: (2019)

Transcriptional Response in Mouse Thyroid Tissue after (211)At Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after Administration
por: Rudqvist, Nils, et al.
Publicado: (2015)

Biodistribution of (131)I in mice is influenced by circadian variations
por: Andersson, Charlotte K., et al.
Publicado: (2020)

Age-related long-term response in rat thyroid tissue and plasma after internal low dose exposure to (131)I
por: Larsson, Malin, et al.
Publicado: (2022)

Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour
por: Kölby, L, et al.
Publicado: (2005)

Objective assessment of tumour response to therapy based on tumour growth kinetics
por: Mehrara, E, et al.
Publicado: (2011)

Objective assessment of tumour response to therapy based on tumour growth kinetics
por: Mehrara, E, et al.
Publicado: (2011)

Analysis of inter-patient variations in tumour growth rate
por: Mehrara, Esmaeil, et al.
Publicado: (2014)

Microdosimetric analysis of (211)At in thyroid models for man, rat and mouse
por: Josefsson, Anders, et al.
Publicado: (2012)

A new method to estimate parameters of the growth model for metastatic tumours
por: Mehrara, Esmaeil, et al.
Publicado: (2013)

Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models
por: Josefsson, Anders, et al.
Publicado: (2014)

Chronic Low Dose Rate Ionizing Radiation Exposure Induces Premature Senescence in Human Fibroblasts that Correlates with Up Regulation of Proteins Involved in Protection against Oxidative Stress
por: Loseva, Olga, et al.
Publicado: (2014)

Transcriptional response in normal mouse tissues after i.v. (211)At administration - response related to absorbed dose, dose rate, and time
por: Langen, Britta, et al.
Publicado: (2015)

The relevance of somatostatin receptors in thyroid neoplasia.
por: Ahlman, H., et al.
Publicado: (1997)

Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma in the Same Patient as a Collision Tumour
por: Dikbas, Oguz, et al.
Publicado: (2019)

Role of Pituitary Tumour Transforming Gene 1 in Medullary Thyroid Carcinoma
por: Zatelli, Maria Chiara, et al.
Publicado: (2010)

Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
por: Wangberg, B., et al.
Publicado: (1996)

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid
por: Tisell, L E, et al.
Publicado: (1999)

Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters
por: Kölby, L, et al.
Publicado: (2003)

The IRI-DICE hypothesis: ionizing radiation-induced DSBs may have a functional role for non-deterministic responses at low doses
por: Langen, Britta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oldbv2dkqhcls7p96ccgeenpbk